Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Feeney

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Clinical Endocrinology|February 28, 2016
Prevalence and correlates of vitamin D deficiency in adults after traumatic brain injuryOmer A Jamall, Claire Feeney, Joanna Zaw-Linn, et al.
Journal of the American Academy of Dermatology|August 20, 2021
Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trialAndrew Blauvelt, Jonathan I Silverberg, Charles W Lynde, et al.
Brain : a Journal of Neurology|December 23, 2017
Minocycline reduces chronic microglial activation after brain trauma but increases neurodegenerationGregory Scott, Henrik Zetterberg, Amy Jolly, et al.
American Journal of Clinical Dermatology|August 25, 2023
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2Gil Yosipovitch, Melinda J Gooderham, Sonja Ständer, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Clinical Endocrinology|February 28, 2016
Prevalence and correlates of vitamin D deficiency in adults after traumatic brain injuryOmer A Jamall, Claire Feeney, Joanna Zaw-Linn, et al.
Journal of the American Academy of Dermatology|August 20, 2021
Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trialAndrew Blauvelt, Jonathan I Silverberg, Charles W Lynde, et al.
Brain : a Journal of Neurology|December 23, 2017
Minocycline reduces chronic microglial activation after brain trauma but increases neurodegenerationGregory Scott, Henrik Zetterberg, Amy Jolly, et al.
American Journal of Clinical Dermatology|August 25, 2023
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2Gil Yosipovitch, Melinda J Gooderham, Sonja Ständer, et al.
Pageof 4